Literature DB >> 56465

Reverse transcriptase activity per virion for avian myeloblastosis virus and Rauscher murine leukemia virus.

L F Liebes, M A Rich, J J McCormick, I Salmeen, L Rimai.   

Abstract

We have measured reverse transcriptase enzyme activity per virus particle for samples of avian myeloblastosis virus (BAI strain) and murine leukemia virus (RAUSCHER) USing the synthetic template poly(rC)-oligo(dG). Absolute virus concentrations were determined directly by laser beat frequency spectroscopy. Enzyme activity per virion was determined from the slope of the activity plotted as a function of virus concentration. With this reverse transcriptase assay, the minimum activity (expressed as picomoles of dGTP incorporated/virion per hour) is estimated at (28.1 +/- 4.2) X 10(-7) for avian myeloblastosis virus and (1.1 +/- 0.2) X 10(-7) for murine leukemia virus. The sensitivity of this assay, which is determined by the level of incorporated radioactivity measurable above background, is 2.5 X 10(-4) virions for avian myeloblastosis virus (with dGTP specific activity of 8.9 Ci/mmol) and 88 X 10(-4) virions for murine leukemia virus (with dGTP specific activity of 6.52 CI/mmol). These results show that although reverse transcriptase assays can obviously be used to measure relative virus concentrations of equally purified samples of the same virus, they can be very misleading when used to compare the concentrations of different virus species.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56465      PMCID: PMC515519     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  Hydrodynamic diameters of RNA tumor viruses. Studies by laser beat frequency light scattering spectroscopy of avian myeloblastosis and Rauscher murine leukemia viruses.

Authors:  I Salmeen; L Rimai; L Liebes; M A Rich; J J McCormick
Journal:  Biochemistry       Date:  1975-01-14       Impact factor: 3.162

2.  Cation preferences for poly(rC)-oligo(dG)-directed DNA synthesis by RNA tumor viruses and human milk particulates.

Authors:  A S Dion; A B Vaidya; G S Fout
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

3.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

4.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

5.  RD-114 virus infectivity assay by measurements of DNA polymerase activity and virus group specific antigen.

Authors:  J E Filbert; R M McAllister; M O Nicolson; R V Gilden; E H Lennette
Journal:  Proc Soc Exp Biol Med       Date:  1974-02

6.  RNase inhibition of reverse transcriptase activity in human milk.

Authors:  J J McCormick; L J Larson; M A Rich
Journal:  Nature       Date:  1974-10-25       Impact factor: 49.962

7.  Comparative biochemical properties of RNA-directed DNA polymerases from Rauscher murine leukemia virus and avian myeloblastosis virus.

Authors:  L C Waters; W K Yang
Journal:  Cancer Res       Date:  1974-10       Impact factor: 12.701

8.  Reverse transcriptase activity of human acute leukaemic cells: purification of the enzyme, response to AMV 70S RNA, and characterization of the DNA product.

Authors:  M G Sarngadharan; P S Sarin; M S Reitz; R C Gallo
Journal:  Nat New Biol       Date:  1972-11-15

9.  Production of mouse mammary tumor virus by cultured cells in the absence and presence of hormones: assay by molecular hybridization.

Authors:  G Ringold; E Y Lasfargues; J M Bishop; H E Varmus
Journal:  Virology       Date:  1975-05       Impact factor: 3.616

10.  In vitro system for production of mouse mammary tumor virus.

Authors:  D L Fine; L O Arthur; J K PLOWMAN; E A Hillman; F Klein
Journal:  Appl Microbiol       Date:  1974-12
  10 in total
  1 in total

1.  Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus.

Authors:  M H Lee; K Sano; F E Morales; D T Imagawa
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.